Irina Antonijevic

Insider Reports History

Location
New Haven, CT
Signature
/s/ George Clark, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Irina Antonijevic:

Company Role Class Num Shares Value Price $ Report Date Ownership
Biohaven Ltd. Director Stock Options (Right to buy) 68,693 28 Apr 2026 Direct
Biohaven Pharmaceutical Holding Co Ltd. Director Restricted Share Unit Award 0 03 Oct 2022 Direct

Insider Reports Filed by Irina Antonijevic

Symbol Company Period Transactions Value $ Form Type Role Filing Time
BHVN Biohaven Ltd. 28 Apr 2026 1 $0 4 Director 30 Apr 2026, 20:08
BHVN Biohaven Ltd. 05 May 2025 1 $0 4 Director 07 May 2025, 17:16
BHVN Biohaven Ltd. 30 Apr 2024 1 $0 4 Director 02 May 2024, 19:33
BHVN Biohaven Ltd. 29 Dec 2023 3 -$459,662 4 Director 29 Dec 2023, 18:25
BHVN Biohaven Ltd. 02 May 2023 1 $0 4 Director 04 May 2023, 17:51
BHVN Biohaven Ltd. 03 Oct 2022 2 $0 4 Director 05 Oct 2022, 17:41
/report/000156218022006954-antonijevic-irina-2022-10-03 Biohaven Pharmaceutical Holding Co Ltd. 03 Oct 2022 1 $0 4 Director 03 Oct 2022, 20:25
BHVN Biohaven Ltd. 28 Sep 2022 0 $0 3 Director 30 Sep 2022, 16:30
/report/000156218022004013-antonijevic-irina-2022-05-11 Biohaven Pharmaceutical Holding Co Ltd. 11 May 2022 1 $0 4 Director 12 May 2022, 20:57
/report/000156218022003981-antonijevic-irina-2022-05-01 Biohaven Pharmaceutical Holding Co Ltd. 01 May 2022 0 $0 3 Director 11 May 2022, 21:26
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .